Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...

The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...

The Trump administration announced late last month "bold actions to tackle the autism epidemic.” President Trump said there was a possible link between acetaminophen, the active ingredient in Tylenol, ...

Scientists have learned more about the genetic factors that may underlie double-jointedness, also known as hypermobility, and diseases that affect connective tissue called hypermobile Ehlers-Danlos ...

The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...

WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children ...

Indication is restricted to CFD-FOLR1 with a confirmed FOLR1 pathogenic variant, encompassing pediatric and adult patients with severe neurodevelopmental and seizure/movement phenotypes. Evidentiary ...

Folate, found in meat and leafy greens, is an important vitamin for neuron function. In some cases, it may be even more important for those whose brains are struggling with energy regulation, such as ...

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease ...